See more : Valartis Group AG (VLRT.SW) Income Statement Analysis – Financial Results
Complete financial analysis of Stemsation International, Inc. (STSN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Stemsation International, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- BellRock Brands Inc. (DXBRF) Income Statement Analysis – Financial Results
- Ultimate Products Plc (ULTP.L) Income Statement Analysis – Financial Results
- DUAL Co., Ltd. (016740.KS) Income Statement Analysis – Financial Results
- Gas Plus S.p.A. (GSP.MI) Income Statement Analysis – Financial Results
- NICO Resources Limited (NICOF) Income Statement Analysis – Financial Results
Stemsation International, Inc. (STSN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.stemsation.global
About Stemsation International, Inc.
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. It offers StemRCM, a dietary supplement that supports stem cells ability to repair, renew, and restore tissues and organ function through healthy stem cell release, circulation, and migration. The company sells its products through independent wellness advocates directly to consumers. StemSation International, Inc. is headquartered in Boca Raton, Florida.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 217.08K | 3.24K | 0.00 | 0.00 | 0.00 | 3.38K | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 116.48K | 258.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 100.60K | 2.98K | 0.00 | 0.00 | 0.00 | 3.38K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 46.34% | 92.03% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.30 | 2.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 294.71 | 2.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 81.61K | 57.44K | 172.66K | 908.49K | 858.04K | 295.00 | 2.53K | 815.00 | 137.14K | 60.11K | 195.12K | 439.01K | 26.64K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 81.61K | 57.44K | 172.66K | 908.49K | 858.04K | 295.00 | 2.53K | 815.00 | 137.14K | 60.11K | 195.12K | 439.01K | 26.64K |
| Cost & Expenses | 81.61K | 57.44K | 172.66K | 1.02M | 858.30K | 295.00 | 2.53K | 815.00 | 137.14K | 60.11K | 195.12K | 439.01K | 26.64K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 29.29 | 27.52 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 19.41K | 238.06K | 170.25K | 241.90K | 66.08K | 0.00 | 0.00 | 25.91K | 0.00 | 0.00 | 2.79K | 8.35K | 0.00 |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 0.30 | 2.53 | 0.00 | 375.00 | 0.00 | 420.00 | 5.63K | 0.00 |
| EBITDA | -67.86K | -57.44K | -172.66K | -803.90K | -770.21K | -295.00 | -2.53K | -815.00 | -133.76K | -60.11K | -194.70K | -433.38K | -26.64K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | -372.18% | -26,423.67% | 0.00% | 0.00% | 0.00% | -3,952.21% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | -81.61K | -57.44K | -172.66K | -807.90K | -855.07K | -300.00 | -2.53K | -820.00 | -133.76K | -60.11K | -195.12K | -439.01K | -26.64K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | -372.18% | -26,423.67% | 0.00% | 0.00% | 0.00% | -3,963.32% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -5.66K | -238.06K | -170.25K | -237.90K | 18.77K | -29.28K | -27.52K | -25.90K | 0.00 | 0.00 | -4.28K | -8.35K | 0.00 |
| Income Before Tax | -87.27K | -295.50K | -342.91K | -1.05M | -836.29K | -29.58K | -30.04K | -26.72K | -133.76K | 0.00 | -199.39K | 0.00 | 0.00 |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | -481.77% | -25,843.45% | 0.00% | 0.00% | 0.00% | -3,963.32% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -167.90K | 142.97K | 811.16K | -206.30K | -171.86K | -0.29 | -2.53 | 0.00 | -2.00 | 60.11K | 67.66K | 8.35K | 26.64K |
| Net Income | -87.27K | -438.48K | -1.15M | -1.05M | -836.29K | -29.58K | -30.04K | -26.72K | -133.76K | -60.11K | -267.06K | -447.36K | -26.64K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | -481.77% | -25,843.45% | 0.00% | 0.00% | 0.00% | -3,963.32% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.06 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 | -0.06 | 0.00 |
| Weighted Avg Shares Out | 209.95M | 192.36M | 187.76M | 203.08M | 89.19M | 24.82M | 26.82M | 24.82M | 16.70M | 15.72M | 12.11M | 7.83M | 6.02M |
| Weighted Avg Shares Out (Dil) | 209.95M | 192.36M | 187.76M | 203.08M | 89.19M | 24.82M | 26.82M | 24.82M | 16.70M | 15.72M | 12.11M | 7.83M | 6.02M |
StemSation International Announces Acquisition of Gorilla Marketing Group, LLC
Strategic Acquisition Completed: StemSation International has finalized the acquisition of Gorilla Marketing Group (GMG), owner of the high-end AlienHouse vape product line. This move positions the company for significant growth in the THC-P vape and lifestyle product markets.
StemSation International Announces Acquisition of Gorilla Marketing Group, LLC
StemSation International announced today the completion of the acquisition of 100% of the private marketing company, Gorilla Marketing Group, LLC Plantation, Florida, December 2, 2024 – PRISM MediaWire – StemSation International (OTC: STSN), a South Florida-based company that has licensed...
StemSation International Announces Execution of a Letter of Intent (LOI) to Acquire Gorilla Marketing Group, LLC
StemSation International announced today the execution of a Letter of Intent outlining the terms for the acquisition of the private marketing company, Gorilla Marketing Group, LLC Plantation, Florida, October 21, 2024 – PRISM MediaWire – StemSation International (OTC: STSN), a...
StemSation International Announces Execution of a Letter of Intent (LOI) to Acquire Gorilla Marketing Group, LLC
PLANTATION, Fla., Oct. 21, 2024 (GLOBE NEWSWIRE) -- StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned oxygen products, is announcing the execution of a Letter of Intent that...
StemSation International Provides Corporate Updates
StemSation International is providing updates on corporate planning and direction as they execute on an expanded business model Plantation, Florida, August 12, 2024 – StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production and...
StemSation International Announces Acquisition Plans
StemSation International is providing updates on corporate planning and direction for potential new acquisitions in the green energy space Plantation, Florida, September 27, 2023 – StemSation International (OTC: STSN), a South-Florida based company that has licensed technology for the production...
StemSation International Announces Corporate Updates
StemSation International is providing updates on recent business activities and new business ventures Plantation, Florida, August 3, 2023 – StemSation International (OTC PINK: STSN), a South-Florida based company that has licensed technology for the production and distribution of flavored, canned...
Source: https://incomestatements.info
Category: Stock Reports